IP Library Granted Patent US 10,144,757
Granted Patent B2
US 10,144,757 · App. 15/618,092 · Granted Dec 4, 2018

Synthetic bile acid compositions and methods

Inventors: Robert M. Moriarty (Michiana Shores, IN); Nathaniel E. David (Los Angeles, CA); Nadir Ahmeduddin Mahmood (Calabasas, CA)
Assignee: Kythera Biopharmaceuticals, Inc.
C07J9/005A61K31/191A61K31/575G01N21/35G01N24/088G01N30/02Y10T436/201666
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,144,757
App. No.
15/618,092
Granted
Dec 4, 2018
Kind
B2
Abstract

Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.

Claims (7)

1. A method for reducing a subcutaneous fat deposit in a subject in need thereof, the method comprising administering locally to a subcutaneous fat deposit in the subject a composition comprising: a fat-dissolving effective amount of deoxycholic acid (DCA) or a salt thereof, wherein the DCA has a 14 C content of less than 0.86 ppt; at least one pharmaceutically acceptable excipient; and optionally a lipid.

2. The method of claim 1 , wherein the subcutaneous fat deposit is associated with a condition selected from the group consisting of obesity, fat redistribution syndrome, eyelid fat herniation, lipomas, Dercum's disease, lipodystrophy, buffalo hump lipodystrophy, dorsocervical fat, visceral adiposity, breast enlargement, hyperadiposity, diffused body fat around trunk and arms, and fat deposits associated with cellulite.

3. The method of claim 1 , wherein the DCA salt is sodium deoxycholate.

4. A method for reducing the appearance of a skin condition in a skin region of a subject in need thereof, the method comprising: administering locally to said skin region a composition comprising: a skin-tightening effective amount of deoxycholic acid or a salt thereof, wherein the DCA has a 14 C content of less than 0.86 ppt; at least one pharmaceutically acceptable excipient; and optionally a lipid; and wherein the skin condition being reduced is loose skin or wrinkles.

5. The method of claim 4 , wherein the administering involves delivering the composition via a subcutaneous or transdermal injection.

6. The method of claim 4 , wherein the skin region is selected from the group consisting of under eye, under chin, under arm, buttock, cheek, brow, calf, back, thigh, ankle, or stomach.

7. The method of claim 4 , wherein the DCA salt is sodium deoxycholate.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Oct 8, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050656/0337 →
CHANGE OF NAME Recorded Oct 4, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050638/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: MORIARTY, ROBERT M.; DAVID, NATHANIEL E.; MAHMOOD, NADIR AHMEDUDDIN
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 047223/0672 →
Continuity (3)
Continuation 14831722 · Aug 20, 2015
Continuation 13816470
Related Publication 20170342101A1 · Nov 30, 2017